119th Congress · introduced in the Senate · Sep 29, 2025
Mobile Cancer Screening Act
Official title from Congress.gov
Latest action (Sep 29, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
11 citations.
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$510,000
Spent on own lobbying
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medic…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$1,790,000
Spent on own lobbying
…s to States to increase awareness and education for colorectal cancer and improve early detection of colorectal cancer. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential scree…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$860,000
Spent on own lobbying
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultraso…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SOCIETY OF THORACIC SURGEONS · lobbying firm or registrant: THE SOCIETY OF THORACIC SURGEONS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$182,593
Spent on own lobbying
Lung Cancer: H.R.4417/ S. 2927- Mobile Cancer Screening Act; would establish a competitive grant program through the Health Resources and Services Administration (HRSA) to fund mobile cancer…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$1,240,000
Spent on own lobbying
…the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Mobile Cancer Screening Act, H.R. 4417, S. 2927. The bill would award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential scree…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Medicare/Medicaid
$700,000
Spent on own lobbying
…Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SOCIETY OF THORACIC SURGEONS · lobbying firm or registrant: THE SOCIETY OF THORACIC SURGEONS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$333,610
Spent on own lobbying
Lung Cancer: H.R.4417/ S. 2927- Mobile Cancer Screening Act; would establish a competitive grant program through the Health Resources and Services Administration (HRSA) to fund mobile cancer…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medicare/Medicaid
$720,000
Spent on own lobbying
…and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; and H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to Medicare site-neutr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SOCIETY OF THORACIC SURGEONS · lobbying firm or registrant: THE SOCIETY OF THORACIC SURGEONS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$183,560
Spent on own lobbying
Lung Cancer: H.R.4417/ S. 2927- Mobile Cancer Screening Act; Would establish a competitive grant program through the Health Resources and Services Administration (HRSA) to fund mobile cancer…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Medicare/Medicaid
$550,000
Spent on own lobbying
…Investment Act; H.R. 1 - One Big Beautiful Bill - provisions related Medicare, Medicaid, and the Affordable Care Act; S. 1410 - Find it Early Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SOCIETY OF THORACIC SURGEONS · lobbying firm or registrant: THE SOCIETY OF THORACIC SURGEONS
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Medical/Disease Research/Clinical Labs
$135,914
Spent on own lobbying
Lung Cancer: H.R.4417/ S. 2927- Mobile Cancer Screening Act; Would establish a competitive grant program through the Health Resources and Services Administration (HRSA) to fund mobile cancer…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing